/
/
/

Fredun Pharmaceuticals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Share Price Live Stats

Open (₹)1,384.70
Volume (₹)1,024.00
High (₹)1,384.70
Upper Circuit1,496.20
Low (₹)1,340.00
Lower Circuit1,224.20
Prev Close1,360.20
52W High (₹)1,600.00
Price1,340.00
52W Low (₹)420.17

Share Market Cap & Key Ratios Overview

M.Cap (₹)2298.69 Cr
Div. Yield (%)0.02
PE Ratio52.46
Debt to Equity0.84
Price to Book3.46
Book Value160.92
EPS (TTM)25.93
Face Value10.00
ROE (%)16.09

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
FREDUN-BNSE
LTP
1W Low
1W High
Market cap (₹)
1849+13.5 (0.74%)
1835.50
1890.40
4,44,597Cr
9589.5+222.5 (2.38%)
9305.95
9739.85
2,55,195Cr
4948.85+144.6 (3.01%)
4864.80
5010
1,87,712Cr
1195.15+42.15 (3.66%)
1152
1208.20
1,17,705Cr
1403.85+32.4 (2.36%)
1364
1420.50
1,13,423Cr
1987.35+32.1 (1.64%)
1964.50
2054.55
1,09,481Cr
2487.8+169.8 (7.33%)
2302.30
2511.80
1,02,229Cr
1198.85+27.75 (2.37%)
1186.20
1221.60
1,00,195Cr
1708.05-26.95 (-1.55%)
1690
1739.60
98,965Cr
2085.9-58.8 (-2.74%)
2080
2129.85
95,939Cr
1340+34.15 (2.62%)
1300
1411.25
2,299Cr

Key Highlights of Fredun Pharmaceuticals Ltd’s P&L

In 2026-03-31, Fredun Pharmaceuticals Ltd reported total revenue of ₹639.13Cr, compared with ₹456.27Cr in 2025-03-31, reflecting Fredun Pharmaceuticals Ltd turnover.

Depreciation was ₹8.25Cr and finance costs were ₹39.32Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹47Cr in 2026-03-31 as compared to ₹27.49Cr in 2025-03-31.

Net Profit (PAT) was ₹32.62Cr in 2026-03-31 compared with ₹19.74Cr in 2025-03-31.

Earnings per share (EPS) were ₹59.61 in 2026-03-31, compared with ₹41.80 in 2025-03-31.